This influential matched‑cohort study followed more than 20,000 adults and found that people prescribed common sleep medications (hypnotics) had a threefold increase in mortality risk, even when taking fewer than 18 pills per year. The analysis showed a clear dose–response pattern, with higher use linked to greater risk. Several widely used hypnotics—including zolpidem, temazepam, eszopiclone, zaleplon, benzodiazepines, barbiturates, and sedating antihistamines—were associated with elevated mortality and increased cancer incidence in heavy users.
Why it matters for longevity at work:
Sleep medication use is common among employees experiencing stress, burnout, or disrupted sleep. This study highlights the importance of non‑pharmacological sleep strategies, workplace recovery practices, and early intervention. For organisations focused on long‑term employee wellbeing, it reinforces the need to prioritise sleep hygiene, circadian alignment, and behavioural sleep support over routine hypnotic use.
